Article
Intra- and Inter-Tumoral Homogeneity of BRAF(V600E) Mutations in Melanoma Tumors.
The Journal of investigative dermatology - 1 Dec 2015
Riveiro-Falkenbach Erica, Villanueva Cándida A, Garrido María C, Ruano Yolanda, García-Martín Rosa M, Godoy Elena, Ortiz-Romero Pablo L, Ríos-Martín Juan J, Santos-Briz Angel, Rodríguez-Peralto José L
Abstract excerpt
The era of targeted therapy has introduced a new therapeutic perspective for melanoma patients. Treatment with BRAFV600 inhibitors has improved overall and disease-free survival in metastatic melanoma patients whose tumors harbor BRAFV600 mutations. Although the BRAFV600E mutation appears to have a critical role in tumor initiation, its expression during tumor progression remains controversial. In fact, various...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
